Menu
Advanced
Structure search
List search
EN
CN
ES
FR
JP
KR
Wish Lists
Cart
Sign in
Sign in
Contact us
Catalog
of Screening Compounds
Screening Libraries
Building Blocks
Advanced
Structure search
List search
Homepage
>
Company
>
Media
>
Pharma News
>
2018
Pharma News, 2018
Pfizer to replace longtime CEO Read with veteran Bourla
(Reuters) - Pfizer Inc (PFE.
Nobel Prize in Physics is shared by a woman, the first in 55 years
The Nobel Prize in Physics has been awarded to a woman for the first time in 55 years, and for only the third time in its history.
U.S. FDA has approved VIZIMPRO® (dacomitinib), a kinase inhibitor for the first-line treatment of patients with metastatic non-small cell lung cancer
Pfizer Inc.
1 October - International Day of Older Persons
Almost 700 million people are now over the age of 60.
Generic Cialis: A Win for Teva and Eli Lilly’s Worst Nightmare
Just a year after launching their generic version of Pfizer’s erectile dysfunction (ED) drug Viagra (sildenafil), Teva is taking on another blockbuster as they prepare to debut gener...
Two Scientists Have Won The Nobel Prize In Medicine For Cancer Therapy
Two scientists have been awarded the 2018 Nobel Prize in physiology or medicine for a method of harnessing the immune system to attack cancer.
U.S. FDA approves Lilly migraine drug; price same as rivals
NEW YORK (Reuters) - Eli Lilly and Co on Thursday said the U.
Chronic illnesses: UN stands up to stop 41 million avoidable deaths per year
“Heart disease, stroke, cancer, diabetes, chronic Lyme disease, depression” – just some of the illnesses outlined by World Health Organization (WHO) chief Dr.
Ten minutes of exercise a day might improve memory: study
LOS ANGELES, Sept.
An Inhibitor of GSK3B and HDACs Kills Pancreatic Cancer Cells and Slows Pancreatic Tumor Growth and Metastasis in Mice
Growth, progression, and drug resistance of pancreatic ductal adenocarcinomas (PDACs) have been associated with increased levels and activity of glycogen synthase kinase 3 beta (GSK3B)...
Janssen hands back rights to imetelstat
Janssen Biotech has decided to terminate a collaboration and license agreement with Geron Corp for experimental cancer drug imetelstat.
Lilly’s snaps up Chugai’s experimental diabetes drug
Lilly has entered into an agreement to develop Chugai’s OWL833, a oral non-peptidic GLP-1 receptor agonist currently in Phase I for type II diabetes.
15
16
17
18
19
20
21
22
23
0
item
s
in Cart
Cart Subtotal:
Go to cart
You will be able to Pay Online or Request a Quote
Catalog
Services
Company
Catalog of Screening Compounds
Screening Libraries
Focused and Target Libraries
Active Reference Sets
Diversity Libraries
Preplated libraries
Inhibitors and Approved Drugs
Screening Compounds
Building blocks
Inhibitors and approved drugs
Drug Discovery Services
Custom chemistry. Chemistry FTE. Resynthesis.
Hit Follow up Support
Medicinal chemistry FTE
In silico drug design (CADD)
Discovery Biology. Biology FTE. In vitro studies.
Animal models
Toxicology and safety
ADME, DMPK. In vivo studies
Chemistry, manufacturing and controls
Company
News & Media
Contact us
Trends in discovery compounds